Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Cancer statistics, 2022
2022 Standout
Cancer statistics, 2023
2023 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
1999
Cancer statistics, 2020
2020 Standout
Cancer statistics, 2024
2024 Standout
Cancer Statistics, 2021
2021 Standout
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Pancreatic cancer
2004 Standout
Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma
1999 Standout
From traditional Chinese medicine to rational cancer therapy
2007 Standout
Management of cancer pain
1999 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
Triggering and modulation of apoptosis by oxidative stress
2000 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Cancer Statistics, 2006
2006 Standout
Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence
2004
Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer
2007 Standout
Pancreatic cancer
2016 Standout
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
2005 Standout
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
1997 Standout
Phase II evaluation of gallium nitrate by continuous infusion in breast cancer
1989
Chemotherapy for pancreatic carcinoma
1996
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
1991
Pancreatic Adenocarcinoma
2014 Standout
Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer
1989
Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence
2005
Targeting multidrug resistance in cancer
2006 Standout
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Phase I trial of sequential topotecan followed by etoposide in adults with myeloid leukemia: a National Cancer Institute of Canada Clinical Trials Group Study
1999
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.
1996
Cancer treatment and survivorship statistics, 2012
2012 Standout
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia
2006
Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden
2006
Phantom auditory perception (tinnitus): mechanisms of generation and perception
1990 Standout
Pancreatic Cancer
2010 Standout
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
The biology and therapy of adult acute lymphoblastic leukemia
2003
Acute Myeloid Leukemia
1999
Cancer as an evolutionary and ecological process
2006 Standout
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor and Ara-C exert synergistic toxicity against human AML HL-60 cells
1999
Autologous peripheral blood stem cell transplantation for acute myeloid leukemia
2011
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence
2005
Pancreatic cancer
2011 Standout
Preliminary results of concurrent radiotherapy and chemotherapy with cis-platinum, vincristine, and bleomycin in bulky, advanced cervical carcinoma: A pilot study
1992
Wound repair and regeneration: Mechanisms, signaling, and translation
2014 Standout
Acute Myeloid Leukemia
2015 Standout
A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients
2015
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Intensified and Shortened Cyclical Chemotherapy for Adult Acute Lymphoblastic Leukemia
2002
Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered
1999
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
Cis-diamminedichloroplatinum II based combination chemotherapy for the control of extensive paraaortic lymph node metastasis in cervical cancer
1987
Stretchable and Soft Electronics using Liquid Metals
2017 Standout
Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias
2006
High‐dose cytosine arabinoside in the treatment of acute myeloid leukemia
2006
The role of radiotherapy in cancer treatment
2005 Standout
Toward the potential cure of leukemias in the next decade
2018
Combination therapy in combating cancer
2017 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
Immune responses and long‐term disease recurrence status after telomerase‐based dendritic cell immunotherapy in patients with acute myeloid leukemia
2017
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
2001 Standout
Chemotherapy prolongs survival in inoperable pancreatic carcinoma
1994
A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia
2014
Cancer treatment and survivorship statistics, 2019
2019 Standout
Effect of Diagnosis (Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, or Acute Myeloid Leukemia [AML]) on Outcome of AML-Type Chemotherapy
1997
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Systematic Review of Barriers to the Recruitment of Older Patients With Cancer Onto Clinical Trials
2005
Simultaneous radiation and chemotherapy for advanced carcinoma of the cervix
1987
Phase I Trial of Twice-Weekly Gemcitabine and Concurrent Radiation in Patients With Advanced Pancreatic Cancer
1999
WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML).
2005
Mechanisms of Therapeutic Activity for Gallium
1998
International experiences with the Hospital Anxiety and Depression Scale-A review of validation data and clinical results
1997 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML
2014
Sense and nonsense of high-dose cytarabine for acute myeloid leukemia
2013
Cancer treatment and survivorship statistics, 2014
2014 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of Weick Jk being referenced
Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group Study.
1982
Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
1980
Gallium nitrate in malignant lymphoma: a Southwest Oncology Group study.
1983
Simultaneous treatment with cisplatin and radiation therapy for advanced solid tumors: a pilot study.
1981
Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy
1989
Phase II evaluation of teniposide and ifosfamide in refractory adult acute lymphocytic leukemia: a Southwest Oncology Group Study.
1987
Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy
1989
A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study
1996